Jazz Pharmaceuticals
JAZZ
#2195
Rank
NZ$11.97 B
Marketcap
$198.07
Share price
6.75%
Change (1 day)
-12.04%
Change (1 year)

EPS for Jazz Pharmaceuticals (JAZZ)

EPS in 2023 (TTM): -$2.13

According to Jazz Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$2.35. In 2022 the company made an earnings per share (EPS) of -$5.89 an increase over its 2021 EPS that were of -$8.95.

EPS history for Jazz Pharmaceuticals from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.13-63.8%
2022-$5.89-34.2%
2021-$8.95-224.83%
2020$7.17-53.25%
2019$15.3423.59%
2018$12.41-8.24%
2017$13.5223.74%
2016$10.9322.12%
2015$8.95478.49%
2014$1.55-74.93%
2013$6.17-27.11%
2012$8.4769.1%
2011$5.01245.98%
2010$1.45-462.5%
2009-$0.40-96.7%
2008-$12.11-27.04%
2007-$16.6065.47%
2006-$10.03-4.59%
2005-$10.51

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$6.69 185.11%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$13.79-687.94%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.22-365.25%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-$3.33 41.84%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel